Literature DB >> 12107203

Intraoperative testosterone assay for virilizing ovarian tumor topographic assessment: report of a Leydig cell tumor of the ovary in a premenopausal woman with an adrenal incidentaloma.

C Regnier1, A Bennet, D Malet, T Guez, M Plantavid, P Rochaix, X Monrozies, J-P Louvet, P Caron.   

Abstract

Ovarian virilizing tumors are rare and can lead to assessment difficulties because of their small size. A 41-yr-old female was referred for evaluation of hirsutism that had increased within the previous 3 yr. Menstrual cycle length was normal. Plasma testosterone was 3.9 ng/ml (normal range, 0.2-0.8 ng/ml), was not suppressible by 2 mg dexamethasone (4.3 ng/ml), and was increased (6.3 ng/ml) after three daily injections of hCG (5000 IU). Abdominal computed tomography scan showed an adrenal nodule (13 x 6 mm) that remained unchanged after 3 months. Ultrasound examination of the pelvis was normal. Ovarian and adrenal venous catheterization did not yield additional information. Topographic assessment was made by intraoperative measurement of testosterone in the samples taken from each ovarian vein (competitive chemiluminescent immunoassay ADVIA Centaur; right ovarian vein, 105 ng/ml; left ovarian vein, 5 ng/ml; peripheral blood, 7 ng/ml). Right annexectomy resulted in normalization of testosterone levels (0.22 ng/ml). Histopathological examination found a Leydig cell tumor of hilar type (1.5 cm). This observation illustrates the usefulness of intraoperative measurement of testosterone by a rapid automated technique for topographic assessment of ovarian virilizing tumor in premenopausal women.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12107203     DOI: 10.1210/jcem.87.7.8583

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Virilising ovarian tumour in a woman with an adrenal nodule.

Authors:  Maria Luisa Cecilia Rivera-Arkoncel; Debby Pacquing-Songco; Frances Lina Lantion-Ang
Journal:  BMJ Case Rep       Date:  2010-12-14

2.  Use of F 18-fluoro-D-glucose-positron emission tomography-computed tomography to localize a hilar cell tumor of the ovary.

Authors:  Desireé M McCarthy-Keith; Micah Hill; John M Norian; Corina Millo; Jeffrey McKeeby; Alicia Y Armstrong
Journal:  Fertil Steril       Date:  2010-04-02       Impact factor: 7.329

3.  Influence of Altered Hormonal Status on Platelet 5-HT and MAO-B Activity in Cigarette Smokers.

Authors:  Pannuru Padmavathi; Vaddi Damodara Reddy; Kodidela Swarnalatha; Reddyvari Hymavathi; N Ch Varadacharyulu
Journal:  Indian J Clin Biochem       Date:  2014-02-11

4.  SEVERE HYPERANDROGENISM IN A PREMENOPAUSAL WOMAN WITH AN IMAGING-NEGATIVE LEYDIG CELL TUMOR.

Authors:  Stephanie B Lubchansky; Ruth McManus
Journal:  AACE Clin Case Rep       Date:  2020-06-23

5.  Adrenal Incidentaloma Camouflaging an Ovarian Leydig Cell Tumour: A Look Beneath the Surface.

Authors:  Harsh Durgia; Sadishkumar Kamalanathan; Jayaprakash Sahoo; Murali Subbaiah; Nachiappa G Rajesh; Sagili Vijaya Bhaskar Reddy
Journal:  J Obstet Gynaecol India       Date:  2021-02-18

6.  "Occult" ovarian Leydig cell tumor: when laboratory tells more than imaging.

Authors:  Rosa Maria Paragliola; Francesco Torino; Paola Senes; Laura Castellino; Vanda Salutari; Alfredo Pontecorvi; Giovanni Scambia; Salvatore M Corsello
Journal:  Endocrine       Date:  2013-10-04       Impact factor: 3.633

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.